MedAvail to Report 2022 First Quarter Financial Results on May 12, 2022
April 28 2022 - 4:05PM
Business Wire
MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”) a
technology-enabled pharmacy company, today announced it will report
financial results for the first quarter of 2022 on Thursday, May
12, 2022, after market close. MedAvail management will be
webcasting a corresponding conference call beginning at 1:30 p.m.
Pacific Time / 4:30 p.m. Eastern Time.
Live audio of the webcast will be available on the “Investor
Relations” section of MedAvail’s website at:
https://investors.medavail.com. The webcast will be archived and
available for replay after the event.
About MedAvail
MedAvail Holdings, Inc. (NASDAQ: MDVL) is a technology-enabled
pharmacy organization, providing turnkey in-clinic pharmacy
services through its proprietary robotic dispensing platform, the
MedAvail MedCenter, and home delivery operations, to Medicare
clinics. MedAvail helps patients to optimize drug adherence,
resulting in better health outcomes. Learn more at
www.medavail.com.
About SpotRx
SpotRx places control of the pharmacy experience back in the
hands of consumers. SpotRx is a telehealth platform that delivers
remote pharmacist consultations through an on-site dispensing
kiosk, supplemented with home delivery capability.
SOURCE MedAvail Holdings, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220428006181/en/
Investor Relations Caroline Paul Gilmartin Group
ir@medavail.com
MedAvail (NASDAQ:MDVL)
Historical Stock Chart
From Mar 2024 to Apr 2024
MedAvail (NASDAQ:MDVL)
Historical Stock Chart
From Apr 2023 to Apr 2024